Måndag 24 Augusti | 20:50:23 Europe / Stockholm
Est. tid*
2026-08-24 16:15 Kvartalsrapport 2026-Q2
2026-05-01 - X-dag ordinarie utdelning DAC 0.00 DKK
2026-04-30 - Årsstämma
2026-04-15 - Bokslutskommuniké 2025
2026-03-04 - Extra Bolagsstämma 2026
2025-08-25 - Kvartalsrapport 2025-Q2
2025-04-29 - X-dag ordinarie utdelning DAC 0.00 DKK
2025-04-28 - Årsstämma
2025-04-04 - Bokslutskommuniké 2024
2024-08-26 - Kvartalsrapport 2024-Q2
2024-04-19 - X-dag ordinarie utdelning DAC 0.00 DKK
2024-04-18 - Årsstämma
2024-03-25 - Bokslutskommuniké 2023
2023-08-28 - Kvartalsrapport 2023-Q2
2023-04-25 - X-dag ordinarie utdelning DAC 0.00 DKK
2023-04-24 - Årsstämma
2023-03-23 - Bokslutskommuniké 2022
2022-08-29 - Kvartalsrapport 2022-Q2
2022-04-28 - X-dag ordinarie utdelning DAC 0.00 DKK
2022-04-27 - Årsstämma
2022-03-28 - Bokslutskommuniké 2021
2021-04-13 - X-dag ordinarie utdelning DAC 0.00 DKK
2021-04-12 - Årsstämma
2021-03-09 - Bokslutskommuniké 2020
2020-04-21 - X-dag ordinarie utdelning DAC 0.00 DKK
2020-04-20 - Årsstämma
2020-03-20 - Bokslutskommuniké 2019
LandDanmark
ListaFirst North Denmark
SektorHälsovård
IndustriMedicinteknik
Danish Aerospace and Defence Company är verksamt inom IT-sektorn. Bolaget är en teknisk leverantör av produkter för satellit- och rymdsektorn, med en patenterad produktportfölj som huvudsakligen inkluderar träningsutrustning, biomedicinsk utrustning, tjänster för hälsoövervakning, samt vattenfiltreringsprodukter. Kunderna består av internationella rymdorganisationer. Huvudkontoret ligger i Odense.

Analysera bolaget i Börsdata!

All ägardata du vill ha finns i Holdings!

Danish Aerospace & Defence Company A/S issues Interim report for 2026

2026-08-24 17:55:00

COMPANY ANNOUNCEMENT

Odense, August 24th, 2026

Company Announcement no. 90 - 24-08-2026

Danish Aerospace & Defence Company A/S issues Interim report for 2026

The Board of Directors of Danish Aerospace and Defence Company A/S (DADC) have today approved the interim report for 2026. The report has not been audited.

Highlights - Interim Report 2026

  • Revenue was DKK 8.2 million, while Gross Profit was DKK 5.7 million.
  • Operating Profit (EBITDA) was DKK -2.0 million, a decrease compared to the same period last year, when EBITDA was DKK 423K.
  • Net profit was DKK -2.3 million compared to DKK -570K last year.
  • In April 2026, DADC completed a rights issue and raised gross proceeds of DKK 24.7 million, where 81.99% of the New Shares was subscribed through the exercise of Pre-emptive Rights and through New Shares not subscribed for by exercise of Pre-emptive Rights.
  • The E4D PFM (First flight model) comprising 294 kg DADC hardware is now installed and operational in the Columbus module. As of today, E4D has been used regularly, since released for exercises, for various combinations of powered and unpowered exercises with cycling, rowing, rope pulling and resistive exercise. It has accumulated 31 hours run time. (10 in unpowered mode).
  • DADC signed a contract change notice with the European Space Agency ESA, to develop and build a Motion Capture (MoCap) system for its E4D exercise equipment which will be launched and tested on the International Space Station. This system holds potential both for Human missions to the Moon and Mars, as well as for ground defense application including recovery training for injured combat personnel.
  • DADC has delivered the first two models of its multifunction exercise device, E4D, under a contract with a commercial customer.
  • DADC is continuing the close dialogue with multiple commercial US and European human spaceflight and defence customers concerning partnership opportunities and delivery of equipment.
  • The dynamic situation in global civil spaceflight right now has affected our market in the short term. As a result, a number of expected orders has not yet materialized. As a consequence, DADC today changes its guidance for 2026. Nevertheless, in the longer term DADC remains well positioned to provide our key exercise- and medical monitoring equipment for future human space- and defence programs and other extreme environments customers.
  • Guidance for the fiscal year 2026:
    • Total Revenue (incl. other income) of DKK 18-20 million; and
    • Operating profit (EBITDA) of approx. DKK -2 to 0 million.

CEO, Thomas A. E. Andersen, states:

“We are extremely pleased to see our E4D hardware now in operation on the International Space Station. E4D is now being used regularly, and we are gaining a lot of experience and receiving extremely valuable feedback from the crew members exercising on it.

Now we are developing the latest addition to E4D, the MoCap system, which also holds potential for defense applications, which is in line with our strategy of pursuing development of dual-use applications where possible”.

Interim Report - Danish Aerospace & Defence Company

Online presentation of key items from the Interim Report 2026 will be held on August 25th at 09:45. Join the event using the following link: DADC Interim Report 2026 online event

Attachments:

Appendix 1 – Key Figures – Interim 2026

Appendix 2 – Changes in Equity 2026

Appendix 3 – Cash Flow 2026

Note: This is a translation of the corresponding Company Announcement in Danish. In case of discrepancies between the Danish wording and the English translation, the Danish wording prevails.

For further information, please contact:

Danish Aerospace and Defence Company A/S:

CEO Thomas A.E. Andersen

Cell: +45 40 29 41 62

Certified Adviser:

HC Andersen Capital

ca@hcandersencapital.dk
Mobil: 30 93 18 87
Bredgade 23B, 2. 1260 København K

About Danish Aerospace and Defence Company A/S:

Danish Aerospace and Defence Company (DADC) is a high-tech company operating in the area of advanced medical instrumentation and other engineering fields primarily within space applications.

Our products are based on many years of specialized research and development. These consist of developing, integrating, and applying new as well as established medical technologies to the challenges of functioning and remaining reliable in space. These products and services bring the potential of space research and experience from space operations down to Earth for the benefit of all mankind.

Danish Aerospace and Defence Company employ engineers and technicians who deliver full engineering, production and technical services for our customers. We specialize in customer specific design, development, manufacturing, certification, maintenance, testing, and operations.

The company has developed five generations of respiratory equipment for spaceflight, ergometers for astronauts, countermeasures, adapted several commercial medical equipment for spaceflight and has participated in the development of the minus eighty-degree Celsius freezers.

The Company’s quality system is certified in obligation to BS EN ISO 9001:2015, BS EN 9100:2018 technical equivalent to AS9100D that is the acknowledged standard in the area.

Note: This is a translation of the corresponding Company Announcement in Danish. In case of discrepancies between the Danish wording and the English translation, the Danish wording prevails.

www.DanishAerospace.com

Appendix 1 - Key figures - Interim 2026

 

1/1-2026 -

30/6-2026

1/1-2025 -

30/6-2025

Revenue8,226,4519,775,062
Gross profit/loss5,747,4937,888,413
Other Operating Income69,183284,451
EBITDA-1,999,752423,193
Operating profit/loss-2,208,662195,785
Net financials-735,903-938,075
Net Profit/loss for the period-2,324,136-570,308
Total assets29,308,02428,158,676
Equity22,919,2737,801,083

Share performance Earnings per share (DKK)

Total number of shares

No. of shares (on average)

Closing share price (DKK)

-0,12

19,220,026

15,082,814

4,37

-0.05

10,982,872

10,945,601

8.4

 

Appendix 2 - Changes in Equity Interim 2026

 Share capital Share premium Reserve for development costs Retained earnings Total
DKK DKK DKK DKK DKK
Equity at 1 January1,098,287 0 8,026,003 -4,411,531 4,712,759
Capital increase823,715 23,887,747 0 0 24,711,462
Costs related to the share issue0 0 0 -4,180,812 -4,180,812
Development costs for the period0 0 839,611 -839,611 0
Depreciation, amortisation and impairment for the period0 0 -29,154 29,154 0
Transfer from share premium0 23,887,747 0 23,887,747 0
Net profit/loss for the period0 0 0 -2,324,136 -2,324,136
Equity at 30 June1,922,002  0 8,836,460 12,160,811 22,919,273

Appendix 3 - Cash flow Interim 2026

  1/1-2026 - 1/1-2025 -
 6/30-2026 6/30-2025
 DKK DKK
Net profit/loss for the period -2,324,136 -570,308
Adjustments 115,474 994,905
Change in working capital -4,254,131 -386,356
Cash flows from operating activities before financial income and expenses -6,462,793 38,241
Financial income 7,220 97,813
Financial expenses -743,623 -1,035,888
Cash flows from operating activities -7,199,196 -889,834
Purchase of intangible assets -1,134,429 -894,095
Purchase of property, plant and equipment -85,283 -36,635
Cash flows from investing activities -1,219,712 -930,730
Raising of loans from credit institutions -12,299,328 -300,822
Loans to group enterprises 0 55,592
Change in loans from owners and Management 0 1,500,000
Capital increase 20,530,650 478,561
Cash flows from financing activities 8,231,322 1,733,331
Change in cash and cash equivalents -187,586 -97,233
Cash and cash equivalents at 1 January 200,143 297,379
Cash and cash equivalents at 30 June 12,557 200,143